Research Article
Open Access
MBNL1 alternative splicing isoforms play opposing roles in cancer
View ORCID ProfileTommaso Tabaglio, Diana HP Low, Winnie Koon Lay Teo, Pierre Alexis Goy, Piotr Cywoniuk, Heike Wollmann, View ORCID ProfileJessica Ho, Damien Tan, Joey Aw, Andrea Pavesi, Krzysztof Sobczak, Dave Keng Boon Wee, View ORCID ProfileErnesto Guccione Correspondence email
Tommaso Tabaglio
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
2Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Diana HP Low
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
3Cancer Science Institute, Singapore
Winnie Koon Lay Teo
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
Pierre Alexis Goy
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
2Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Piotr Cywoniuk
4Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Poznan, Poland
Heike Wollmann
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
Jessica Ho
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
Damien Tan
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
Joey Aw
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
Andrea Pavesi
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
Krzysztof Sobczak
4Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Poznan, Poland
Dave Keng Boon Wee
5Institute of High Performance Computing, Agency for Science, Technology and Research, Singapore
8Bioinformatics Institute, Agency for Science, Technology and Research, Singapore
Ernesto Guccione
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
2Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
3Cancer Science Institute, Singapore
6National Cancer Centre Singapore, Singapore
7Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Published 7 September 2018. DOI: 10.26508/lsa.201800157
Statistics from Altmetric.com
Article usage
Dissecting the function of MBNL1 exon 7-containing isoforms
Tommaso Tabaglio, Diana HP Low, Winnie Koon Lay Teo, Pierre Alexis Goy, Piotr Cywoniuk, Heike Wollmann, Jessica Ho, Damien Tan, Joey Aw, Andrea Pavesi, Krzysztof Sobczak, Dave Keng Boon Wee, Ernesto Guccione
Life Science Alliance Sep 2018, 1 (5) e201800157; DOI: 10.26508/lsa.201800157
Dissecting the function of MBNL1 exon 7-containing isoforms
Tommaso Tabaglio, Diana HP Low, Winnie Koon Lay Teo, Pierre Alexis Goy, Piotr Cywoniuk, Heike Wollmann, Jessica Ho, Damien Tan, Joey Aw, Andrea Pavesi, Krzysztof Sobczak, Dave Keng Boon Wee, Ernesto Guccione
Life Science Alliance Sep 2018, 1 (5) e201800157; DOI: 10.26508/lsa.201800157
In this Issue
Volume 1, No. 5
October 2018
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- FMRP-Regulated Alternative Splicing is Multifactorial and Resembles Splicing Control by MBNL1
- Muscleblind-like proteins use modular domains to localize RNAs by riding kinesins and docking to membranes
- RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing
- Altered Expression of MBNL Family of Alternative Splicing Factors in Colorectal Cancer
- The transcriptional repressor BCL11A promotes breast cancer metastasis
- A tumor-associated splice-isoform of MAP2K7 drives dedifferentiation in MBNL1-low cancers via JNK activation
- Muscleblind-like 2 controls the hypoxia response of cancer cells
- Identification of RBPMS as a smooth muscle master splicing regulator via proximity of its gene with super-enhancers